Thomas Engstrom
Clinical trials sponsored by Thomas Engstrom, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart attack procedures aim to save more lives and prevent repeat attacks Results expected Feb 2027 (estimated)
-
Steroid shot before angioplasty may limit heart damage
Disease control CompletedThis study tested whether giving a single, strong dose of steroids to people right after a major heart attack (STEMI) could reduce the amount of heart muscle that gets permanently damaged. The steroid was given before the standard emergency procedure to open the blocked artery. T…
Phase 2 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Late heart attack intervention: helpful or not?
Knowledge-focused CompletedThis study looked at 150 patients who had a heart attack 12 to 36 hours earlier. Researchers wanted to see if opening the blocked artery right away was better than waiting a few days. They used MRI scans to measure heart muscle damage and function.
Sponsor: Thomas Engstrom • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC